Quality of life of palliative care patients in the last two weeks of life
Publication in refereed journal

Times Cited
Web of Science37WOS source URL (as at 28/11/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractQuality of life (QOL) is the main consideration in caring for advanced, cancer patients, yet little is known about the QOL in the terminal phase. We profiled the QOL of 58 advanced cancer patients during their last 2 weeks of life using the McGill QOL questionnaire-Hong Kong version. The patients provided ratings of QOL an average of 5.6 (median 6) days pre-death. Palliative care services were successful in maintaining the total QOL score during the dying phase. The mean score was 7.0 of 10. Among the various domains, the physical. and existential domains scored relatively poorly at 5.9 and 6 of 10, respectively. The worst physical symptom and meaning of life were the individual items with the poorest scores (4.8 and 5.4 of 10, respectively). Compared with admission, there was statistically significant improvement in the worst physical symptom (P = 0.02) and eating item (P = 0.002), but deterioration in physical well-being (P = 0.03), meaning of existence (P = 0.007), and satisfaction with oneself (P = 0.04). In conclusion, QOL evaluation during the terminal phase identifies important aspects requiring improvement during the last two weeks of life. Physical and existential domains of dying cancer patients needed more attention.
All Author(s) ListLo RSK, Woo J, Zhoc KCH, Li CYP, Yeo W, Johnson P, Mak Y, Lee J
Journal nameJournal of Pain and Symptom Management
Volume Number24
Issue Number4
Pages388 - 397
LanguagesEnglish-United Kingdom
Keywordsadvanced cancer; end of life; Hong Kong; hospice; palliative care; quality of life; terminal illness
Web of Science Subject CategoriesClinical Neurology; CLINICAL NEUROLOGY; General & Internal Medicine; Health Care Sciences & Services; HEALTH CARE SCIENCES & SERVICES; Medicine, General & Internal; MEDICINE, GENERAL & INTERNAL; Neurosciences & Neurology

Last updated on 2020-29-11 at 02:23